Statin reduces the incidence of diabetic retinopathy and its need for intervention: A systematic review and meta-analysis.

European Journal of Ophthalmology
Raymond PranataAndi Arus Victor

Abstract

We aimed to perform a systematic literature search on the latest evidence of the role of statin in reducing diabetic retinopathy and its need for intervention. A comprehensive search on cohort studies/clinical trials that assess statins and diabetic retinopathy up until August 2019 was performed. The outcome measured was the incidence of diabetic retinopathy and its need for intervention. There were 558.177 patients from six studies. Statin was associated with a lower incidence of diabetic retinopathy (hazard ratio: 0.68 (0.55, 0.84), p < 0.001; I2: 95%). For the subtypes of diabetic retinopathy, statin lowers the incidence of proliferative diabetic retinopathy (hazard ratio: 0.69 (0.51, 0.93), p = 0.01; I2: 90%), non-proliferative diabetic retinopathy (hazard ratio: 0.80 (0.66, 0.96), p = 0.02; I2: 93%), and diabetic macular edema (hazard ratio: 0.56 (0.39, 0.80), p = 0.002; I2: 82%). Statin was associated with a reduced need for retinal laser treatment with a hazard ratio of 0.70 (0.64, 0.76) (p < 0.001; I2: 0%), intravitreal injection with a hazard ratio of 0.82 (0.79, 0.85) (p < 0.001; I2: 0%), and vitrectomy with a hazard ratio of 0.64 (0.48, 0.85) (p < 0.001; I2: 75%). Overall, statin was associated with a reduced need fo...Continue Reading

References

May 28, 2005·Diabetes Care·Manon V van HeckeUNKNOWN EURODIAB prospective complications study
Aug 19, 2007·Archives of Ophthalmology·Jie Zhang, Gerald McGwin
Jul 1, 2010·The New England Journal of Medicine·UNKNOWN ACCORD Study GroupLawrence J Fine
Jan 14, 2011·The New England Journal of Medicine·Emily Y Chew, Walter T Ambrosius
Sep 5, 2012·Indian Journal of Ophthalmology·Yingfeng ZhengNathan Congdon
Dec 13, 2012·JAMA : the Journal of the American Medical Association·Fang KoDavid S Friedman
Aug 31, 2014·Ophthalmology·Emily Y ChewUNKNOWN Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group
Sep 14, 2014·The Lancet. Diabetes & Endocrinology·Sune F Nielsen, Børge G Nordestgaard
Nov 19, 2014·Canadian Journal of Physiology and Pharmacology·Rosa FernandesPaulo Pereira
Jul 1, 2015·Genetics and Molecular Research : GMR·M C BiE Song
Aug 16, 2016·Current Diabetes Reports·Jared E KnickelbeinEmily Y Chew
Feb 1, 2017·World Journal of Diabetes·Estelle IoannidouKonstantinos Tziomalos
May 27, 2017·Vision Research·Sandra S Hammer, Julia V Busik
Jul 28, 2017·JAMA Ophthalmology·Jeffrey R WillisRonald A Cantrell
May 19, 2018·Diabetes Spectrum : a Publication of the American Diabetes Association·Emily Frith, Paul D Loprinzi
Jan 11, 2019·JAMA Ophthalmology·Eugene Yu-Chuan KangYih-Shiou Hwang
Jan 1, 2018·Ophthalmology Retina·Chi-Juei JengI-Jong Wang
Sep 11, 2019·European Heart Journal·François MachUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Citations

Nov 27, 2020·Frontiers in Immunology·John V ForresterMirela Delibegovic

❮ Previous
Next ❯

Software Mentioned

ACCORD
Stata
EYE
Review Manager

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.